This is a big deal, Folks! Asante Solutions, maker of the new Snap insulin pump, just signed an agreement to make its data protocols open and available via the new open-source Tidepool Platform. This means that for the first time ever, a pump maker is going straight to the cloud, committing to an open system that will allow users to combine their pump data with CGM data and other records, and view and share that…Read more »
We were so pleased to host two key individuals from the FDA at this year’s DiabetesMine Innovation Summit: Courtney Lias, Director of CDRH/Division of Chemistry and Toxicology (who gave one of the opening talks updating us on FDA progress), and her colleague Stayce Beck, head of the FDA’s artificial pancreas team. Their involvement in this patient-led leadership forum is proof that the ePatient Revolution is changing the dynamics of health and medicine policy!
Last week, we heard about Google’s attempt to measure glucose levels through contact lenses. Now imagine being able to check your glucose levels just by sticking a thermometer under your tongue for a few seconds.
Believe it or not, there’s a new company on the scene working on a diabetes device that would use nothing more than a bit of your spit to take a glucose reading.
It’s called the iQuickIt Saliva Analyzer (that’s a…
Jiangfeng Fei is the new Senior Manager of New Technology Development for the JDRF Artificial Pancreas Project (APP). His responsibilities include “identification of new device development opportunities that fill key gaps to accelerate the goals of the JDRF APP, and acting as the scientific lead on current device-related partnerships with industry and academic investigators.” We were thrilled to include him in the recent 2013 DiabetesMine Innovation Summit at Stanford University — and equally thrilled to…Read more »
John Sjolund is the CEO and co-founder of Timesulin, a company that makes a clever digital insulin pen cap that keeps track of your dosing. You may have heard about their launch in Canada on Oct. 1 and Finland in mid-November, but we’re still awaiting word on the timeline for a U.S. launch… Meanwhile, as head of this company and also a person living with type 1 diabetes for over a quarter-century, John is uniquely…Read more »